Clinical Trial Update: Bendamustine Plus Subcutaneous Rituximab in Patients With Diffuse Large B-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating bendamustine with subcutaneous rituximab in patients with diffuse large B-cell lymphoma; the study status is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Rituxan (rituximab)
• Treanda (Bendamustine)

Snippet

Sponsor: Asan Medical Center | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: UNKNOWN